DM

David Koerber, MBA

Director of Business Development - Advanced Radioisotopes and Therapeutic Technologies (ARTT) at NorthStar Medical Radioisotopes, LLC

David Koerber, MBA has a diverse work experience spanning over two decades. David currently holds the position of Director of Business Development - Advanced Radioisotopes and Therapeutic Technologies (ARTT) at NorthStar Medical Radioisotopes, LLC, where they are responsible for growing the portfolio of accounts in the therapeutics and contract drug manufacturing areas. Prior to this role, David worked at Curium Pharma, where they served as a Senior Area Business Manager, managing an assigned territory of accounts consisting of radiopharmacies, hospitals, and outpatient centers. Additionally, they held the position of Senior Product Marketing Manager at Curium Pharma, where they spearheaded marketing initiatives and represented customer product specifications and requirements. Before joining Curium, David worked at Mallinckrodt Pharmaceuticals, where they held various roles including Senior Product Marketing Manager, Product Marketing Manager, Product Manager of Generators, Senior Account Manager of Nuclear Medicine, Nuclear Medicine Business Sales Consultant, Imaging Account Manager, Asset Operations Analyst, Distributor Administration Analyst, and Traffic Expeditor. Throughout these roles, David demonstrated success in launching new products, managing customer relationships, and driving sales and business growth.

David Koerber has a Master of Business Administration (MBA) degree from Webster University, which they obtained in 2013. Prior to that, they earned a Bachelor of Arts (BA) degree in Business Administration from Lindenwood University in 2003. David also holds a Certificate in Business/Corporate Communications from Duke University, which they completed in 2016.

In terms of additional certifications, David obtained the Microsoft Excel Advanced certification from EXECUTRAIN in 2015. David also completed the Nuclear Pharmacy Practice Fundamentals certification at the University of Arkansas in 2008.

Links

Previous companies

Mallinckrodt logo

Timeline

  • Director of Business Development - Advanced Radioisotopes and Therapeutic Technologies (ARTT)

    April, 2023 - present